To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
Affymetrix and Invitrogen Enter into Licensing Agreement
Read time: Less than a minute
Affymetrix Inc.
and
Invitrogen Corporation
has announced that Invitrogen has obtained a non-exclusive, worldwide license to a number of Affymetrix patents that will allow Invitrogen to manufacture and sell spotted nucleic acid microarrays in the research field.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
